Medtronic (MDT) Stock Price, News & Analysis

Company Overview

Medtronic plc is a medical technology company that develops and manufactures devices and therapies for a range of health conditions. Its products include pacemakers and defibrillators, heart valves, surgical technologies, neurostimulation devices, and insulin pumps and other diabetes-management products.

The company was founded in Minneapolis in 1949 by Earl Bakken and Palmer Hermundslie as a medical equipment repair business. It has since grown into a global company serving patients and health care providers in more than 150 countries.

Medtronic is headquartered in Dublin, Ireland, and maintains significant operations in Minnesota, where the company was founded. Its technologies are used in hospitals, clinics, and other health care settings around the world.

Key Stats

• Today's Range: $100.02 to $101.82
• 50-Day Range: $85.51 to $105.02
• 52-Week Range: $73.31 to $106.33
• Volume: 4.39 million shs
• Average Volume: 14.66 million shs
• Market Capitalization: $130.01 billion
• P/E Ratio: 25.03
• Dividend Yield: 2.83%
• Price Target: $102.88
• Consensus Rating: Moderate Buy

Medtronic Stock Analysis - MarketRank™

Medtronic scored higher than 89% of companies evaluated by MarketBeat, and ranked 31st out of 896 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.61, and is based on no strong buy ratings, 18 buy ratings, 9 hold ratings, and 1 sell rating.

Upside/Downside

The consensus price target for Medtronic is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Medtronic has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 6.19%

Earnings Growth

Earnings for Medtronic are expected to grow by 6.19% in the coming year, from $5.98 to $6.35 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medtronic is 25.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.05.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medtronic is 25.03, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.27.

Price to Earnings Growth Ratio

Medtronic has a PEG Ratio of 2.38. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Medtronic has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.80% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1.86, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently decreased by 83.49%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Medtronic pays a meaningful dividend of 2.83%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Medtronic has been increasing its dividend for 49 years.

Dividend Coverage

The dividend payout ratio of Medtronic is 70.94%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Medtronic will have a dividend payout ratio of 45.35% next year. This indicates that Medtronic will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.7 / 5
• News Sentiment: 0.98

News Sentiment

Medtronic has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 30 news articles for Medtronic this week, compared to 9 articles on an average week.

Search Interest

Only 35 people have searched for MDT on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.

MarketBeat Follows

26 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 63% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Medtronic insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,889,203.00 in company stock.

Percentage Held by Insiders

0.27% of the stock of Medtronic is held by insiders.

Percentage Held by Institutions

82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 9/01/2026
• Record date for 10/16 Dividend: 9/25/2026
• Ex-Dividend for 10/16 Dividend: 9/25/2026
• Dividend Payable: 10/16/2026
• Today: 11/12/2026
• Next Earnings (Estimated): 11/24/2026
• Fiscal Year End: 4/30/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:MDT
• CIK: 1613103
• Web: www.medtronic.com
• Phone: (531) 438-1700
• Fax: 763-514-4879
• Employees: 95,000
• Year Founded: 1949

Price Target and Rating

• Average Price Target for Medtronic: $102.88
• High Price Target: $118.00
• Low Price Target: $83.00
• Potential Upside/Downside: +1.2%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.61
• Research Coverage: 28 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.06
• Trailing P/E Ratio: 25.03
• Forward P/E Ratio: 16.01
• P/E Growth: 2.38
• Net Income: $4.80 billion
• Net Margins: 13.93%
• Pretax Margin: 17.59%
• Return on Equity: 14.78%
• Return on Assets: 7.97%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 2.07
• Quick Ratio: 1.54

Sales & Book Value

• Annual Sales: $36.36 billion
• Price / Sales: 3.58
• Cash Flow: $7.85 per share
• Price / Cash Flow: 12.94
• Book Value: $39.00 per share
• Price / Book: 2.61

Miscellaneous

• Outstanding Shares: 1,279,140,000
• Free Float: 1,275,684,000
• Market Cap: $130.01 billion
• Optionable: Optionable
• Beta: 0.56